您的位置: 首页 > 农业专利 > 详情页

Combined telomerase inhibitor and gemcitabine for the treatment of cancer
专利权人:
GERON CORPORATION
发明人:
GO, NING,TRESSLER, ROBERT J.
申请号:
DK07867297
公开号:
DK2101789T3
申请日:
2007.10.30
申请国别(地区):
DK
年份:
2015
代理人:
摘要:
A method and kit for inhibiting the proliferation of cancer cells are disclosed, based on a combination of a gemcitabine and a telomerase inhibitor. When used in cancer therapy, the two compounds in combination enhance the anti-cancer treatment efficacy obtained with gemcitabine alone or the telomerase inhibitor alone. Preferably, efficacy is supraadditive or synergistic in nature relative to the combined effects of the individual agents, with minimal exacerbation of side effects.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充